Use of a cyclo-oxygenase type-2-selective non-steroidal anti-inflammatory agent to prevent preterm delivery [6]

Lancet

Volumn 350, Issue 9073, 1997, Pages 265-266

  Sawdy, R ^a   Slater, D ^a   Fisk, N ^a   Edmonds, D K ^a   Bennett, P ^a  

^a QUEEN CHARLOTTE S AND CHELSEA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CYCLOOXYGENASE 2 INHIBITOR; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; CASE REPORT; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LETTER; PREMATURE LABOR; PRIORITY JOURNAL;

EID: 0030860088     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62229-5     Document Type: Article

References (5)

1. MJNC Keirse Indomethacin tocolysis in preterm labour. In: Cochrane Library [CDROM and online]: review no 04383. Cochrane Collection; issue 22 1995 Update Software Oxford
2. SK Hendricks JR Smith DE Moore ZA Brown Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour Br J Obstet Gynaecol 97 1990 312 316
3. D Slater L Berger GE Moore PR Bennett Changes in the expression of types 1 and 2 cyclo-oxygenase in human fetal membranes at term Am J Obstet Gynecol 172 1995 77 82
4. JR Vane RM Botting Mechanisms of action of anti-inflammatory drugs J Vane R Botting G Botting Improved non-steroid anti-inflammatory drugs: COX-2 enzyme inhibitors 1996 Kluwer Academic UK 1 27
5. KJ Moise Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use Am J Obstet Gynecol 168 (5) 1993 1350 1353